Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
O'Reilly Automotive
ORLY
$74.9B
| $137M | 0.19% |
7,618,500
+4,396,500
| +136% | +$79.4M |
|
102
Telus
TU
$15.2B
| $137M | 0.19% |
8,433,496
+1,572,296
| +23% | +$25.8M |
|
103
Vodafone
VOD
$36.7B
| $137M | 0.19% |
5,174,200
-3,218,656
| -38% | -$82.4M |
|
104
AbbVie
ABBV
$442B
| $136M | 0.19% |
2,087,956
+1,737,156
| +495% | +$109M |
|
|
FLG
105
Flagstar Bank National Association
FLG
$5.89B
| $135M | 0.19% |
3,215,559
+237,298
| +8% | +$10.7M |
|
106
British American Tobacco
BTI
$122B
| $134M | 0.19% |
2,021,000
+483,600
| +31% | +$29.9M |
|
107
SiriusXM
SIRI
$9.61B
| $134M | 0.19% |
2,594,590
-502,810
| -16% | -$24.7M |
|
108
WIX.com
WIX
$2.79B
| $133M | 0.19% |
1,951,700
+361,400
| +23% | +$21.2M |
|
109
Sempra
SRE
$55.9B
| $131M | 0.18% |
2,379,200
-696,800
| -23% | -$37M |
|
|
TSE
110
DELISTED
Trinseo
TSE
| $131M | 0.18% |
1,956,900
+315,500
| +19% | +$21.2M |
|
111
Kimberly-Clark
KMB
$36.1B
| $131M | 0.18% |
991,500
+468,300
| +90% | +$59.1M |
|
|
NLSN
112
DELISTED
Nielsen Holdings plc
NLSN
| $130M | 0.18% |
3,155,856
+2,047,456
| +185% | +$87.6M |
|
113
Berkshire Hathaway Class A
BRK.A
$1.11T
| $127M | 0.18% |
507
+82
| +19% | +$20.6M |
|
114
Danaher
DHR
$146B
| $125M | 0.17% |
1,646,090
-70,839
| -4% | -$5.27M |
|
|
WR
115
DELISTED
Westar Energy Inc
WR
| $125M | 0.17% |
2,295,300
+1,138,400
| +98% | +$62M |
|
|
AGN
116
DELISTED
Allergan plc
AGN
| $124M | 0.17% |
+520,069
| New | +$121M |
|
117
Old Republic International
ORI
$10.2B
| $123M | 0.17% |
6,009,785
+2,291,700
| +62% | +$46.3M |
|
118
Canadian Pacific Kansas City
CP
$80.8B
| $123M | 0.17% |
4,179,000
+1,824,000
| +77% | +$54.2M |
|
119
Alcoa
AA
$14.3B
| $121M | 0.17% |
3,503,996
+1,592,700
| +83% | +$55.7M |
|
120
General Mills
GIS
$20.2B
| $118M | 0.17% |
2,004,300
+1,190,200
| +146% | +$72.8M |
|
|
FNSR
121
DELISTED
Finisar Corp
FNSR
| $117M | 0.16% |
4,287,000
+126,400
| +3% | +$3.87M |
|
|
APC
122
DELISTED
Anadarko Petroleum
APC
| $117M | 0.16% |
+1,886,800
| New | +$126M |
|
123
Advanced Micro Devices
AMD
$774B
| $117M | 0.16% |
8,023,026
-3,507,300
| -30% | -$44.5M |
|
124
Chemours
CC
$2.23B
| $117M | 0.16% |
3,031,400
+1,746,100
| +136% | +$52.6M |
|
125
Hershey
HSY
$36.6B
| $116M | 0.16% |
1,060,000
+147,900
| +16% | +$15.9M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.